Systematic Financial Management’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,744
| Closed | -$1.73M | – | 252 |
|
|
2023
Q4 | $1.73M | Sell |
25,744
-19,771
| -43% | -$1.38M | 0.05% | 179 |
|
|
2023
Q3 | $3.41M | Sell |
45,515
-1,336
| -3% | -$119K | 0.11% | 151 |
|
|
2023
Q2 | $4.32M | Sell |
46,851
-3,247
| -6% | -$289K | 0.14% | 146 |
|
|
2023
Q1 | $5.19M | Sell |
50,098
-7,188
| -13% | -$797K | 0.17% | 142 |
|
|
2022
Q4 | $6.61M | Sell |
57,286
-5,891
| -9% | -$686K | 0.22% | 142 |
|
|
2022
Q3 | $6.85M | Buy |
63,177
+11,879
| +23% | +$1.7M | 0.25% | 138 |
|
|
2022
Q2 | $9.26M | Buy |
51,298
+1,441
| +3% | +$258K | 0.32% | 121 |
|
|
2022
Q1 | $8.52M | Buy |
+49,857
| New | +$9.4M | 0.27% | 133 |
|
|
2019
Q3 | – | Sell |
-735
| Closed | -$94K | – | 605 |
|
|
2019
Q2 | $94K | Buy |
+735
| New | +$102K | ﹤0.01% | 600 |
|
|
2018
Q4 | – | Sell |
-6,333
| Closed | -$1.4M | – | 669 |
|
|
2018
Q3 | $1.4M | Sell |
6,333
-2,880
| -31% | -$584K | 0.03% | 391 |
|
|
2018
Q2 | $1.48M | Sell |
9,213
-6,595
| -42% | -$843K | 0.04% | 346 |
|
|
2018
Q1 | $1.48M | Sell |
15,808
-6,425
| -29% | -$480K | 0.03% | 307 |
|
|
2017
Q4 | $1.55M | Sell |
22,233
-5,155
| -19% | -$342K | 0.03% | 361 |
|
|
2017
Q3 | $1.63M | Sell |
27,388
-10,300
| -27% | -$513K | 0.03% | 353 |
|
|
2017
Q2 | $1.56M | Buy |
37,688
+945
| +3% | +$41.1K | 0.03% | 513 |
|
|
2017
Q1 | $1.63M | Sell |
36,743
-3,760
| -9% | -$162K | 0.03% | 475 |
|
|
2016
Q4 | $1.69M | Sell |
40,503
-80
| -0.2% | -$3.22K | 0.03% | 477 |
|
|
2016
Q3 | $1.53M | Sell |
40,583
-15,510
| -28% | -$556K | 0.02% | 502 |
|
|
2016
Q2 | $1.87M | Buy |
56,093
+2,195
| +4% | +$70.8K | 0.03% | 349 |
|
|
2016
Q1 | $1.63M | Buy |
53,898
+150
| +0.3% | +$4.38K | 0.02% | 445 |
|
|
2015
Q4 | $1.63M | Sell |
53,748
-15,215
| -22% | -$453K | 0.02% | 460 |
|
|
2015
Q3 | $1.85M | Sell |
68,963
-10,245
| -13% | -$298K | 0.02% | 530 |
|
|
2015
Q2 | $2.56M | Buy |
79,208
+8,133
| +11% | +$258K | 0.02% | 396 |
|
|
2015
Q1 | $2.13M | Buy |
71,075
+1,940
| +3% | +$61.6K | 0.02% | 574 |
|
|
2014
Q4 | $2.32M | Sell |
69,135
-2,590
| -4% | -$80.7K | 0.02% | 457 |
|
|
2014
Q3 | $2.35M | Buy |
71,725
+11,900
| +20% | +$365K | 0.02% | 424 |
|
|
2014
Q2 | $1.82M | Buy |
+59,825
| New | +$1.86M | 0.01% | 587 |
|
|
2013
Q4 | – | Sell |
-58,690
| Closed | -$1.58M | – | 675 |
|
|
2013
Q3 | $1.58M | Buy |
58,690
+8,510
| +17% | +$228K | 0.01% | 409 |
|
|
2013
Q2 | $1.29M | Buy |
+50,180
| New | +$1.32M | 0.01% | 574 |
|
Other funds holding MED
Systematic Financial Management's MED Position: Q1 2024 in Review
Systematic Financial Management sold out of Medifast (MED) in Q1 2024, closing a stake of 25,744 shares — an estimated $1.73M sold.
Systematic Financial Management first reported a position in MED in Q2 2013 and held it in 29 quarters. The position peaked at $9.26M in Q2 2022. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.
- Systematic Financial Management reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
- Systematic Financial Management sold 25,744 Medifast shares in Q1 2024, an estimated $1.73M.
- Systematic Financial Management first reported a position in Medifast in Q2 2013 and held it in 29 quarters.
- Systematic Financial Management's Medifast position peaked at $9.26M in Q2 2022.
- 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.
Based on Systematic Financial Management's 13F filing for Q1 2024, filed 15 May 2024.